Factors impacting enrollment on NCI-COG Pediatric MATCH trial treatment protocols.

10007Background: The NCI-Children’s Oncology Group (COG) Pediatric Molecular Analysis for Therapy Choice (MATCH) trial assigns patients age 1 to 21 years with relapsed or refractory solid tumors, l...